Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: Correlation with antibody vaccine immunogenicity

Vaccine

Volumn 23, Issue 14, 2005, Pages 1686-1694

  Capelle, Martinus A H ^a   Brügger, Peter ^b   Arvinte, Tudor ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adjuvant; Fluorescence spectroscopy; Immune response; Light scatter; Monoclonal antibody

Indexed keywords

ALUMINUM; ALUMINUM HYDROXIDE; PHOSPHATE BUFFERED SALINE; VACCINE; WATER;

ANIMAL MODEL; ANISOTROPY; AQUEOUS SOLUTION; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG FORMULATION; FEMALE; FLUORESCENCE SPECTROSCOPY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VIVO STUDY; KINETICS; LIGHT SCATTERING; NONHUMAN; PH; POLYMERIZATION; PRIORITY JOURNAL; RAT; SEDIMENTATION; SPECTROSCOPY;

EID: 13444266248     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.031     Document Type: Article

References (37)

1. M.S. Co, J. Baker, and K. Bednarik Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys Cancer Res 56 5 1996 1118 1125
2. E. Nudelman, S.B. Levery, T. Kaizu, and S. Hakomori Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6) J Biol Chem 261 24 1986 11247 11253
3. C.B. Siegall Targeted therapy of carcinomas using BR96 sFv-PE40, a single-chain immunotoxin that binds to the Le(y) antigen Semin Cancer Biol 6 5 1995 289 295
4. L.H. Pai, R. Wittes, A. Setser, M.C. Willingham, and I. Pastan Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin Nat Med 2 3 1996 350 353
5. P.P. Deshpande, and S.J. Danishefsky Total synthesis of the potential anticancer vaccine KH-1 adenocarcinoma antigen Nature 387 6629 1997 164 166
6. M. Blaszczyk-Thurin, J. Thurin, O. Hindsgaul, K.A. Karlsson, Z. Steplewski, and H. Koprowski Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy J Biol Chem 262 1 1987 372 379
7. Z. Steplewski, M. Blaszczyk-Thurin, M. Lubeck, H. Loibner, D. Scholz, and H. Koprowski Oligosaccharide Y specific monoclonal antibody and its isotype switch variants Hybridoma 9 2 1990 201 210
8. N. Taschner, S.A. Muller, and V.R. Alumalla Modulation of antigenicity related to changes in antibody flexibility upon lyophilization J Mol Biol 310 1 2001 169 179
9. R.K. Gupta, and G.R. Siber Adjuvants for human vaccines-current status, problems and future prospects Vaccine 13 14 1995 1263 1276
10. M. Singh, and D. O'Hagan Advances in vaccine adjuvants Nat Biotechnol 17 11 1999 1075 1081
11. J. Cox, and A. Coulter Prospects for the development of new vaccine adjuvants BioDrugs 12 6 1999 439 453
12. R.K. Gupta Aluminum compounds as vaccine adjuvants Adv Drug Deliv Rev 32 3 1998 155 172
13. B. Metz, W. Jiskoot, W.E. Hennink, D.J. Crommelin, and G.F. Kersten Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines Vaccine 22 2 2003 156 167
14. T. Azumi, and S.P. McGlynn Polarization of luminescence of pheantrene J Chem Phys 37 1962 2413 2420
15. C.R. Cantor, and P.R. Schimmel Biophysical Chemistry; Part II: Techniques for the study of biological structure and function 1980 W.H. Freeman and Co. New York
16. T.M. Laue, and W.F. Stafford III Modern applications of analytical ultracentrifugation Annu Rev Biophys Biomol Struct 28 1999 75 100
17. J. Lebowitz, M.S. Lewis, and P. Schuck Modern analytical ultracentrifugation in protein science: a tutorial review Protein Sci 11 9 2002 2067 2079
18. E.L. Cussler Diffusion, mass transfer in fluid systems 2nd ed. 1997 Cambridge University Press Cambridge
19. J.F. Dufreche, J.P. Simonin, and P. Turq Sedimentation of charged colloids in the gravitational field: relaxation toward equilibrium J Mol Liq 79 2 1999 137 149
20. E. Muralidharan, N. Tateishi, and N. Maeda Simultaneous influence of erythrocyte deformability and macromolecules in the medium on erythrocyte aggregation: a kinetic study by a laser scattering technique Biochim Biophys Acta 1194 2 1994 255 263
21. C.D. Kuo, J.J. Bai, I.T. Chang, J.H. Wang, and S. Chien Continuous monitoring of erythrocyte sedimentation process: a new possible mechanism of erythrocyte sedimentation J Biomech Eng 110 4 1988 392 395
22. World Health Organization. Immunological adjuvants. World Health Organization Technical Report Series No. 595. Geneva: World Health Organization; 1976, p. 6.
23. M.A. Aprile, and A.C. Wardlaw Aluminium compounds as adjuvants for vaccines and toxoids in man: a review Can J Public Health 57 8 1966 343 360
24. D. Jankovic, P. Caspar, and M. Zweig Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120 J Immunol 159 5 1997 2409 2417
25. M.F. Chang, Y. Shi, and S.L. Nail Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits Vaccine 19 20-22 2001 2884 2889
26. J.M. Heimlich, F.E. Regnier, J.L. White, and S.L. Hem The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins Vaccine 17 22 1999 2873 2881
27. R.E. Baier, and R.C. Dutton Initial events in interactions of blood with a foreign surface J Biomed Mater Res 3 1 1969 191 206
28. R.K. Gupta, B.E. Rost, E. Relyveld, and G.R. Siber Adjuvant properties of aluminum and calcium compounds M.F. Powell M.J. Newman Vaccine design: the subunit and adjuvant approach 1995 Plenum Press New York 229 248
29. G. Ott, r. Radhakrishnan, J.-W. Fang, and M. Hora The adjuvant MF59: a 10-year perspective D. O'Hagan Vaccine adjuvants: preparation methods and research protocols vol. 12 2000 Humana Press Emeryville 211 228
30. L.C. Paoletti, M.A. Rench, D.L. Kasper, D. Molrine, D. Ambrosino, and C.J. Baker Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines Infect Immun 69 11 2001 6696 6701
31. W. Matheis, A. Zott, and M. Schwanig The role of the adsorption process for production and control combined adsorbed vaccines Vaccine 20 12 2001 67 73
32. J.V. Rinella Jr., J.L. White, and S.L. Hem Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins Vaccine 14 4 1996 298 300
33. M.F. Chang, J.L. White, S.L. Nail, and S.L. Hem Role of the electrostatic attractive force in the adsorption of proteins by aluminum hydroxide adjuvant PDA J Pharm Sci Technol 51 1 1997 25 29
34. R.H. al Shakhshir, F.E. Regnier, J.L. White, and S.L. Hem Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants Vaccine 13 1 1995 41 44
35. R.H. al Shakhshir, F.E. Regnier, J.L. White, and S.L. Hem Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants Vaccine 12 5 1994 472 474
36. R.P. Weissburg, P.W. Berman, and J.L. Cleland Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum Pharm Res 12 10 1995 1439 1446
37. L.S. Burrell, E.B. Lindblad, J.L. White, and S.L. Hem Stability of aluminium-containing adjuvants to autoclaving Vaccine 17 20-21 1999 2599 2603